These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 23840887)
1. Deletion of C7L and K1L genes leads to significantly decreased virulence of recombinant vaccinia virus TianTan. Liu Z; Wang S; Zhang Q; Tian M; Hou J; Wang R; Liu C; Ji X; Liu Y; Shao Y PLoS One; 2013; 8(7):e68115. PubMed ID: 23840887 [TBL] [Abstract][Full Text] [Related]
2. Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes. Dai K; Liu Y; Liu M; Xu J; Huang W; Huang X; Liu L; Wan Y; Hao Y; Shao Y Vaccine; 2008 Sep; 26(39):5062-71. PubMed ID: 18573290 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and virulence of attenuated vaccinia virus Tian Tan encoding HIV-1 muti-epitope genes, p24 and cholera toxin B subunit in mice. Du S; Wang Y; Liu C; Wang M; Zhu Y; Tan P; Ren D; Li X; Tian M; Yin R; Li C; Jin N J Virol Methods; 2015 Jul; 219():1-9. PubMed ID: 25796990 [TBL] [Abstract][Full Text] [Related]
4. Role of genes that modulate host immune responses in the immunogenicity and pathogenicity of vaccinia virus. Jackson SS; Ilyinskii P; Philippon V; Gritz L; Yafal AG; Zinnack K; Beaudry KR; Manson KH; Lifton MA; Kuroda MJ; Letvin NL; Mazzara GP; Panicali DL J Virol; 2005 May; 79(10):6554-9. PubMed ID: 15858042 [TBL] [Abstract][Full Text] [Related]
5. [Immunogenicity analysis of HIV vaccine based on replicating vaccinia virus Tiantan vector]. Liu Y; Duan DL; Peng H; Tang HL; Liu S; Zhang N; Wang N; Liu JY; Shao YM Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):281-3. PubMed ID: 15640868 [TBL] [Abstract][Full Text] [Related]
6. Seven major genomic deletions of vaccinia virus Tiantan strain are sufficient to decrease pathogenicity. Li Y; Sheng Y; Chu Y; Ji H; Jiang S; Lan T; Li M; Chen S; Fan Y; Li W; Li X; Sun L; Jin N Antiviral Res; 2016 May; 129():1-12. PubMed ID: 26821204 [TBL] [Abstract][Full Text] [Related]
7. Characterization of an attenuated TE3L-deficient vaccinia virus Tian Tan strain. Wang Y; Kan S; Du S; Qi Y; Wang J; Liu L; Ji H; He D; Wu N; Li C; Chi B; Li X; Jin N Antiviral Res; 2012 Dec; 96(3):324-32. PubMed ID: 23084929 [TBL] [Abstract][Full Text] [Related]
8. HIV/AIDS Vaccine Candidates Based on Replication-Competent Recombinant Poxvirus NYVAC-C-KC Expressing Trimeric gp140 and Gag-Derived Virus-Like Particles or Lacking the Viral Molecule B19 That Inhibits Type I Interferon Activate Relevant HIV-1-Specific B and T Cell Immune Functions in Nonhuman Primates. García-Arriaza J; Perdiguero B; Heeney JL; Seaman MS; Montefiori DC; Yates NL; Tomaras GD; Ferrari G; Foulds KE; Roederer M; Self SG; Borate B; Gottardo R; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo AD; Weiss DE; Lee C; Kibler KV; Jacobs BL; Wagner R; Ding S; Pantaleo G; Esteban M J Virol; 2017 May; 91(9):. PubMed ID: 28179536 [TBL] [Abstract][Full Text] [Related]
9. The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes. Zhu W; Fang Q; Zhuang K; Wang H; Yu W; Zhou J; Liu L; Tien P; Zhang L; Chen Z J Virol Methods; 2007 Sep; 144(1-2):17-26. PubMed ID: 17459491 [TBL] [Abstract][Full Text] [Related]
10. Comparison on virulence and immunogenicity of two recombinant vaccinia vaccines, Tian Tan and Guang9 strains, expressing the HIV-1 envelope gene. Zhu R; Huang W; Wang W; Liu Q; Nie J; Meng S; Yu Y; Wang Y PLoS One; 2012; 7(11):e48343. PubMed ID: 23139778 [TBL] [Abstract][Full Text] [Related]
11. Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens. Nájera JL; Gómez CE; García-Arriaza J; Sorzano CO; Esteban M PLoS One; 2010 Jun; 5(6):e11406. PubMed ID: 20613977 [TBL] [Abstract][Full Text] [Related]
12. [The construction of attenuated Tiantan recombinant vaccinia virus vector with IFN-gamma receptor gene deletion]. Huang W; Liu Y; Duan DL; Li HS; Liu Y; Hong KX; Zhu JH; Shao YM Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Mar; 18(1):43-6. PubMed ID: 15340525 [TBL] [Abstract][Full Text] [Related]
13. Improved safety of a replication-competent poxvirus-based HIV vaccine with the introduction of the HSV-TK/GCV suicide gene system. Zhang Q; Liu Z; Hou J; Wang S; Liu C; Wei M; Liu Y; Shao Y Vaccine; 2016 Jun; 34(30):3447-53. PubMed ID: 27195760 [TBL] [Abstract][Full Text] [Related]
14. Generation of an Attenuated Tiantan Vaccinia Virus Strain by Deletion of Multiple Genes. Li Y; Zhu Y; Chen S; Li W; Yin X; Li S; Xiao P; Han J; Li X; Sun L; Jin N Front Cell Infect Microbiol; 2017; 7():462. PubMed ID: 29164070 [TBL] [Abstract][Full Text] [Related]
15. Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges. Khattar SK; Manoharan V; Bhattarai B; LaBranche CC; Montefiori DC; Samal SK mBio; 2015 Jul; 6(4):e01005. PubMed ID: 26199332 [TBL] [Abstract][Full Text] [Related]
16. Generation of an attenuated Tiantan vaccinia virus by deletion of the ribonucleotide reductase large subunit. Kan S; Jia P; Sun L; Hu N; Li C; Lu H; Tian M; Qi Y; Jin N; Li X Arch Virol; 2014 Sep; 159(9):2223-31. PubMed ID: 24677065 [TBL] [Abstract][Full Text] [Related]
17. Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes. Legrand FA; Verardi PH; Jones LA; Chan KS; Peng Y; Yilma TD J Virol; 2004 Mar; 78(6):2770-9. PubMed ID: 14990697 [TBL] [Abstract][Full Text] [Related]
18. Vaccinia virus host range genes. Perkus ME; Goebel SJ; Davis SW; Johnson GP; Limbach K; Norton EK; Paoletti E Virology; 1990 Nov; 179(1):276-86. PubMed ID: 2171207 [TBL] [Abstract][Full Text] [Related]
19. Deletion of multiple genes induces virulence reduction of vaccinia virus Tiantan strain. Li Y; Cui Y; Zhu Y; Li W; Li S; Fang J; Xiao P; Han J; Yao W; Sun L; Jin N; Li X Virus Res; 2020 Jan; 276():197807. PubMed ID: 31707001 [TBL] [Abstract][Full Text] [Related]
20. Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling Pathways. García-Arriaza J; Arnáez P; Gómez CE; Sorzano CÓ; Esteban M PLoS One; 2013; 8(6):e66894. PubMed ID: 23826170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]